Seres Therapeutics Inc (MCRB) — Capital Reinvestment Ratio
Seres Therapeutics Inc (MCRB) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow ($2.21 Million) in capital expenditures ($8.00K). See Seres Therapeutics Inc balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Seres Therapeutics Inc Capital Reinvestment Ratio (2016–2021)
This chart tracks Seres Therapeutics Inc's Capital Reinvestment Ratio across 2 annual periods. Check cash flow reinvestment rate of Seres Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Seres Therapeutics Inc (2016–2021)
Year-by-year Capital Reinvestment Ratio for Seres Therapeutics Inc from 2016 to 2021. For live market cap and broader valuation context, see Seres Therapeutics Inc (MCRB) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 1.43x | $6.69 Million | $9.57 Million | ▲ +192.3% |
| 2016 | 0.49x | $43.92 Million | $21.49 Million | — |